KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Receivables (2016 - 2025)

Humana has reported Receivables over the past 17 years, most recently at $3.4 billion for Q4 2025.

  • Quarterly results put Receivables at $3.4 billion for Q4 2025, up 550.66% from a year ago — trailing twelve months through Dec 2025 was $3.4 billion (up 550.66% YoY), and the annual figure for FY2025 was $3.4 billion, up 550.66%.
  • Receivables for Q4 2025 was $3.4 billion at Humana, up from $2.7 billion in the prior quarter.
  • Over the last five years, Receivables for HUM hit a ceiling of $4.1 billion in Q2 2024 and a floor of $192.0 million in Q2 2021.
  • Median Receivables over the past 5 years was $1.6 billion (2023), compared with a mean of $1.6 billion.
  • Biggest five-year swings in Receivables: soared 781.69% in 2021 and later plummeted 92.25% in 2023.
  • Humana's Receivables stood at $3.1 billion in 2021, then crashed by 40.73% to $1.9 billion in 2022, then tumbled by 71.43% to $530.0 million in 2023, then fell by 0.57% to $527.0 million in 2024, then surged by 550.66% to $3.4 billion in 2025.
  • The last three reported values for Receivables were $3.4 billion (Q4 2025), $2.7 billion (Q3 2025), and $373.0 million (Q2 2025) per Business Quant data.